Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Cash from Financing Activities (2022 - 2025)

LENZ Therapeutics (LENZ) has disclosed Cash from Financing Activities for 4 consecutive years, with $122.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 231249.06% to $122.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $149.7 million through Dec 2025, down 24.75% year-over-year, with the annual reading at $149.7 million for FY2025, 24.75% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $122.6 million at LENZ Therapeutics, up from $598000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $171.3 million in Q1 2024, with the low at -$2.1 million in Q2 2024.
  • Average Cash from Financing Activities over 4 years is $36.0 million, with a median of $505000.0 recorded in 2022.
  • Peak annual rise in Cash from Financing Activities hit 231249.06% in 2025, while the deepest fall reached 99.97% in 2025.
  • Over 4 years, Cash from Financing Activities stood at $244000.0 in 2022, then soared by 33989.75% to $83.2 million in 2023, then plummeted by 99.94% to $53000.0 in 2024, then soared by 231249.06% to $122.6 million in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $122.6 million, $598000.0, and $26.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.